<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
    <channel>
        <itunes:owner>
            <itunes:name>Novo Nordisk Pharmatech A/S</itunes:name>
            <itunes:email>mwvm@novonordisk.com</itunes:email>
        </itunes:owner>
        <title>Novo Nordisk Pharmatech A/S</title>
        <link>https://novonordiskpharmatechas.twentythree.com</link>
        <description></description>
        <language>en-us</language>
        <generator>Visualplatform</generator>
        <docs>http://blogs.law.harvard.edu/tech/rss</docs>
        <itunes:author>Novo Nordisk Pharmatech A/S</itunes:author>
        <itunes:type>episodic</itunes:type>
        <itunes:explicit>no</itunes:explicit>
        <itunes:image href="https://novonordiskpharmatechas.twentythree.com/files/rv1.4/sitelogo.gif"/>
        <image>
            <url>https://novonordiskpharmatechas.twentythree.com/files/rv1.4/sitelogo.gif</url>
            <title>Novo Nordisk Pharmatech A/S</title>
            <link>https://novonordiskpharmatechas.twentythree.com</link>
        </image>
        <atom:link rel="self" href="https://novonordiskpharmatechas.twentythree.com/audiopodcast/tag/growth factor"/>
        <atom:link rel="next" href="https://novonordiskpharmatechas.twentythree.com/audiopodcast/tag/growth factor?tag=growth+factor&amp;p=2&amp;podcast%5fp=t&amp;https="/>
        <item>
            <enclosure url="http://novonordiskpharmatechas.twentythree.com/64968567/85911246/3109a44349c74686c0a2da5b52478834/audio/podcast/85911246-10-audio.mp3" type="audio/mp3" length="12456520"/>
            <title>Presentation: Is recombinant Insulin a factor to consider viral production?</title>
            <link>http://novonordiskpharmatechas.twentythree.com/presentation-is-recombinant-insulin-1</link>
            <description>&lt;p&gt;Based on published studies, our hypothesis is that adding recombinant Insulin to the cell growth media for suspension HEK293 cells would improve viral titre.&lt;p&gt;&lt;/p&gt;
&lt;p&gt;Novo Nordisk Pharmatech will be presenting case studies on Lentivirus and three serotypes of AAVs, where we measured the effect of adding different concentrations of Insulin Human AF at different times during viral production.&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://novonordiskpharmatechas.twentythree.com/presentation-is-recombinant-insulin-1"&gt;&lt;img src="http://novonordiskpharmatechas.twentythree.com/64968567/85911246/3109a44349c74686c0a2da5b52478834/standard/download-10-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://novonordiskpharmatechas.twentythree.com/photo/85911246</guid>
            <pubDate>Thu, 28 Oct 2021 00:00:00 GMT</pubDate>
            <media:title>Presentation: Is recombinant Insulin a factor to consider viral production?</media:title>
            <itunes:summary>Based on published studies, our hypothesis is that adding recombinant Insulin to the cell growth media for suspension HEK293 cells would improve viral titre.
Novo Nordisk Pharmatech will be presenting case studies on Lentivirus and three serotypes of AAVs, where we measured the effect of adding different concentrations of Insulin Human AF at different times during viral production.</itunes:summary>
            <itunes:subtitle>Based on published studies, our hypothesis is that adding recombinant Insulin to the cell growth media for suspension HEK293 cells would improve viral titre.
Novo Nordisk Pharmatech will be presenting case studies on Lentivirus and three serotypes...</itunes:subtitle>
            <itunes:author>Novo Nordisk Pharmatech A/S</itunes:author>
            <itunes:duration>17:18</itunes:duration>
            <media:description type="html">&lt;p&gt;Based on published studies, our hypothesis is that adding recombinant Insulin to the cell growth media for suspension HEK293 cells would improve viral titre.&lt;p&gt;&lt;/p&gt;
&lt;p&gt;Novo Nordisk Pharmatech will be presenting case studies on Lentivirus and three serotypes of AAVs, where we measured the effect of adding different concentrations of Insulin Human AF at different times during viral production.&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://novonordiskpharmatechas.twentythree.com/presentation-is-recombinant-insulin-1"&gt;&lt;img src="http://novonordiskpharmatechas.twentythree.com/64968567/85911246/3109a44349c74686c0a2da5b52478834/standard/download-10-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://novonordiskpharmatechas.twentythree.com/v.ihtml/player.html?token=3109a44349c74686c0a2da5b52478834&amp;source=podcast&amp;photo%5fid=85911246" width="625" height="352" type="text/html" medium="video" duration="1038" isDefault="true" expression="full"/>
            <media:thumbnail url="http://novonordiskpharmatechas.twentythree.com/64968567/85911246/3109a44349c74686c0a2da5b52478834/standard/download-10-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://novonordiskpharmatechas.twentythree.com/64968567/85911246/3109a44349c74686c0a2da5b52478834/standard/download-10-thumbnail.jpg/thumbnail.jpg"/>
            <category>growth factor</category>
            <category>Recombinant Insulin</category>
            <category>viral production</category>
        </item>
        <item>
            <enclosure url="http://novonordiskpharmatechas.twentythree.com/64968575/85911454/55196b7b52f6282acee5dd7de97c9bdf/audio/podcast/85911454-10-audio.mp3" type="audio/mp3" length="13073702"/>
            <title>Why Use Recombinant Insulin in DoE For Your Media Development?</title>
            <link>http://novonordiskpharmatechas.twentythree.com/why-use-recombinant-insulin-in-doe</link>
            <description>&lt;p&gt;The presentation features a case study by the University of Barcelona based on the use of a DOE model for determining optimal levels of nutrients in cell culture media for CHO-S cells, as well as examining the use of human insulin in association with CHO cells to produce mabs and also with HEK-293 cells to replicate influenza virus antigens for vaccines.&lt;/p&gt;&lt;p&gt;&lt;a href="http://novonordiskpharmatechas.twentythree.com/why-use-recombinant-insulin-in-doe"&gt;&lt;img src="http://novonordiskpharmatechas.twentythree.com/64968575/85911454/55196b7b52f6282acee5dd7de97c9bdf/standard/download-10-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://novonordiskpharmatechas.twentythree.com/photo/85911454</guid>
            <pubDate>Thu, 11 Mar 2021 00:00:00 GMT</pubDate>
            <media:title>Why Use Recombinant Insulin in DoE For Your Media Development?</media:title>
            <itunes:summary>The presentation features a case study by the University of Barcelona based on the use of a DOE model for determining optimal levels of nutrients in cell culture media for CHO-S cells, as well as examining the use of human insulin in association with CHO cells to produce mabs and also with HEK-293 cells to replicate influenza virus antigens for vaccines.</itunes:summary>
            <itunes:subtitle>The presentation features a case study by the University of Barcelona based on the use of a DOE model for determining optimal levels of nutrients in cell culture media for CHO-S cells, as well as examining the use of human insulin in association...</itunes:subtitle>
            <itunes:author>Novo Nordisk Pharmatech A/S</itunes:author>
            <itunes:duration>18:09</itunes:duration>
            <media:description type="html">&lt;p&gt;The presentation features a case study by the University of Barcelona based on the use of a DOE model for determining optimal levels of nutrients in cell culture media for CHO-S cells, as well as examining the use of human insulin in association with CHO cells to produce mabs and also with HEK-293 cells to replicate influenza virus antigens for vaccines.&lt;/p&gt;&lt;p&gt;&lt;a href="http://novonordiskpharmatechas.twentythree.com/why-use-recombinant-insulin-in-doe"&gt;&lt;img src="http://novonordiskpharmatechas.twentythree.com/64968575/85911454/55196b7b52f6282acee5dd7de97c9bdf/standard/download-10-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://novonordiskpharmatechas.twentythree.com/v.ihtml/player.html?token=55196b7b52f6282acee5dd7de97c9bdf&amp;source=podcast&amp;photo%5fid=85911454" width="625" height="352" type="text/html" medium="video" duration="1089" isDefault="true" expression="full"/>
            <media:thumbnail url="http://novonordiskpharmatechas.twentythree.com/64968575/85911454/55196b7b52f6282acee5dd7de97c9bdf/standard/download-10-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://novonordiskpharmatechas.twentythree.com/64968575/85911454/55196b7b52f6282acee5dd7de97c9bdf/standard/download-10-thumbnail.jpg/thumbnail.jpg"/>
            <category>DoE</category>
            <category>growth factor</category>
            <category>media development</category>
            <category>Recombinant Insulin</category>
        </item>
    </channel>
</rss>
